The global automatic identification industry association AIM has launched the latest standard for “Medical Electrical Equipment & RFID Reader System Electromagnetic Immunity Test”. This standard provides professional guidance for the testing of non-implantable medical devices to determine whether they are exposed to radiation from the RFID system.
This standard aims to provide medical device manufacturers and end users with guidelines for evaluating the radiation generated by RFID systems on medical devices. The test process specified in the document is based on the experimental results of several AIM members. The test guide covers LF, HF, UHF RFID. Both active and passive RFID standards are within the scope of the guidelines.
The report pointed out that at the beginning of the 21st century, HCI members realized the need to establish a standard for the role of RFID systems and non-implantable medical devices. In 2011, the ISO organization issued “ISO/IEC TR 20017″, which provided information on the interaction between RFID and implantable medical devices. However, this document does not provide any guidelines for non-implantable medical devices. The new standard launched by AIM provides guidelines for non-implantable medical devices and their test methods.
Seth Seidman, an electrical engineer at the U.S. Food and Drug Administration Center for Equipment and Radiology, said: “The release of this standard is an important milestone. RFID system radiation is very demanding for the evaluation of medical devices. Currently, the FDA is evaluating this standard.”
Peter J. Hawrylak, associate professor of electrical and computer engineering at the University of Tulsa, commented: “The establishment of the standard took 3 years. The standard establishment team includes medical equipment testing experts, RFID system design and manufacturing experts, and RFID system integration experts. And end users. External medical equipment manufacturers, users and RFID equipment manufacturers will all benefit from it.”
Post time: Jun-03-2021